-
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy Diabetol. (IF 8.2) Pub Date : 2023-09-29 Marja-Riitta Taskinen, Niina Matikainen, Elias Björnson, Sanni Söderlund, Jussi Inkeri, Antti Hakkarainen, Helka Parviainen, Carina Sihlbom, Annika Thorsell, Linda Andersson, Martin Adiels, Chris J. Packard, Jan Borén
-
Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2023-09-26 Tomoya Mita, Naoto Katakami, Yosuke Okada, Hidenori Yoshii, Takeshi Osonoi, Keiko Nishida, Toshihiko Shiraiwa, Akira Kurozumi, Naohiro Taya, Satomi Wakasugi, Fumiya Sato, Ryota Ishii, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada
-
Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank Diabetol. (IF 8.2) Pub Date : 2023-09-20 Caiwei Tian, Charlyne Bürki, Kenneth E. Westerman, Chirag J. Patel
-
The challenges of identifying and studying type 1 diabetes in adults Diabetol. (IF 8.2) Pub Date : 2023-09-20 Nicholas J. Thomas, Angus G. Jones
-
Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy Diabetol. (IF 8.2) Pub Date : 2023-09-20 Xiaoli Hu, Christian Selmer Buhl, Marie Balle Sjogaard, Karoline Schousboe, Hatice Isik Mizrak, Huda Kufaishi, Troels Staehelin Jensen, Christian Stevns Hansen, Knud Bonnet Yderstræde, Ming-Dong Zhang, Patrik Ernfors, Jens Randel Nyengaard, Pall Karlsson
-
Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study Diabetol. (IF 8.2) Pub Date : 2023-09-19 David M. Wright, Usha Chakravarthy, Radha Das, Katie W. Graham, Timos T. Naskas, Jennifer Perais, Frank Kee, Tunde Peto, Ruth E. Hogg
-
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial Diabetol. (IF 8.2) Pub Date : 2023-09-16 Sara J. Cromer, Tanayott Thaweethai, Deborah J. Wexler
-
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis Diabetol. (IF 8.2) Pub Date : 2023-09-15 Kavaljit H. Chhabra, Siresha Bathina, Tumininu S. Faniyan, Dennis J. Samuel, Muhammad Ummear Raza, Leticia Maria de Souza Cordeiro, Gonzalo Viana Di Prisco, Brady K. Atwood, Jorge Robles, Lauren Bainbridge, Autumn Davis
-
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells Diabetol. (IF 8.2) Pub Date : 2023-09-15 Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, Roberta Cappellari, Angelo Avogaro, Gian Paolo Fadini
-
Quantifying beta cell function in the preclinical stages of type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2023-09-15 Alfonso Galderisi, Alice L. J. Carr, Mariangela Martino, Peter Taylor, Peter Senior, Colin Dayan
-
The metabolic response of human trophoblasts derived from term placentas to metformin Diabetol. (IF 8.2) Pub Date : 2023-09-05 Jane L. Tarry-Adkins, India G. Robinson, Lucas C. Pantaleão, Jenna L. Armstrong, Benjamin D. Thackray, Lorenz M. W. Holzner, Alice E. Knapton, Sam Virtue, Benjamin Jenkins, Albert Koulman, Andrew J. Murray, Susan E. Ozanne, Catherine E. Aiken
-
Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy Diabetol. (IF 8.2) Pub Date : 2023-09-05 Subramanian Dharmarajan, Casandra Carrillo, Zhonghua Qi, Jonathan M. Wilson, Anthony J. Baucum, Christine M. Sorenson, Nader Sheibani, Teri L. Belecky-Adams
-
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment Diabetol. (IF 8.2) Pub Date : 2023-09-04 Emily K. Sims, Susan M. Geyer, S. Alice Long, Kevan C. Herold
-
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing Diabetol. (IF 8.2) Pub Date : 2023-08-31 Alice E. Hughes, Jayne A. L. Houghton, Benjamin Bunce, Ali J. Chakera, Gill Spyer, Maggie H. Shepherd, Sarah E. Flanagan, Andrew T. Hattersley
-
Cystine/glutamate antiporter System xc- deficiency impairs insulin secretion in mice Diabetol. (IF 8.2) Pub Date : 2023-08-31 Axel de Baat, Daniel T. Meier, Leila Rachid, Adriano Fontana, Marianne Böni-Schnetzler, Marc Y. Donath
-
Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy Diabetol. (IF 8.2) Pub Date : 2023-08-24 Ravi Retnakaran, Chang Ye, Caroline K. Kramer, Anthony J. Hanley, Philip W. Connelly, Mathew Sermer, Bernard Zinman
-
Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice Diabetol. (IF 8.2) Pub Date : 2023-08-24 Jian-Ming Li, Xianyu Li, Lawrence W. C. Chan, Ruinian Hu, Tian Zheng, Haojie Li, Sijun Yang
-
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2023-08-24 Claire L. Meek, Zoe A. Stewart, Denice S. Feig, Samuel Furse, Sandra L. Neoh, Albert Koulman, Helen R. Murphy
-
Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy Diabetol. (IF 8.2) Pub Date : 2023-08-19 Jonathan Goldney, Jack A. Sargeant, Melanie J. Davies
-
(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study Diabetol. (IF 8.2) Pub Date : 2023-08-17 Sara B. A. Mokhtar, Frank C. T. van der Heide, Karel A. M. Oyaert, Carla J. H. van der Kallen, Tos T. J. M. Berendschot, Fabio Scarpa, Alessia Colonna, Bastiaan E. de Galan, Marleen M. J. van Greevenbroek, Pieter C. Dagnelie, Casper G. Schalkwijk, Rudy M. M. A. Nuijts, Nicolaas C. Schaper, Abraham A. Kroon, Miranda T. Schram, Carroll A. B. Webers, Coen D. A. Stehouwer
-
Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice Diabetol. (IF 8.2) Pub Date : 2023-08-16 Deyan Yavorov-Dayliev, Fermín I. Milagro, Josune Ayo, María Oneca, Ignacio Goyache, Miguel López-Yoldi, Paula Aranaz
-
Targeting BCAA metabolism to potentiate metformin’s therapeutic efficacy in the treatment of diabetes in mice Diabetol. (IF 8.2) Pub Date : 2023-08-15 Xiaoyun Zhao, Xuejiao Zhang, Jingjing Pei, Yajin Liu, Wenyan Niu, Haipeng Sun
-
Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2023-08-15 Reindert F. Oostveen, Yannick Kaiser, Mia R. Ståhle, Nick S. Nurmohamed, Evangelos Tzolos, Marc R. Dweck, Jeffrey Kroon, Andrew J. Murphy, Damini Dey, Piotr J. Slomka, Hein J. Verberne, Erik S. G. Stroes, Nordin M. J. Hanssen
-
IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity Diabetol. (IF 8.2) Pub Date : 2023-08-15 Sofia Thomaidou, Amadeo Munoz Garcia, Sabine de Lange, Jin Gan, Arno R. van der Slik, Rob C. Hoeben, Bart O. Roep, Françoise Carlotti, Arnaud Zaldumbide
-
Incretins beyond type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2023-08-08 Chantal Mathieu, Iraj Ahmadzai
-
Incretins and cardiovascular disease: to the heart of type 2 diabetes? Diabetol. (IF 8.2) Pub Date : 2023-08-05 Anna Solini, Domenico Tricò, Stefano Del Prato
-
Daniel Porte Jr, 13 August 1931–13 May 2023 Diabetol. (IF 8.2) Pub Date : 2023-08-04 Steven E. Kahn, Michael W. Schwartz
-
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory Diabetol. (IF 8.2) Pub Date : 2023-08-04 Robert Moulder, Tommi Välikangas, M. Karoliina Hirvonen, Tomi Suomi, Caroline A. Brorsson, Niina Lietzén, Sylvaine F. A. Bruggraber, Lut Overbergh, David B. Dunger, Mark Peakman, Piotr J. Chmura, Soren Brunak, Anke M. Schulte, Chantal Mathieu, Mikael Knip, Laura L. Elo, Riitta Lahesmaa
-
SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cells Diabetol. (IF 8.2) Pub Date : 2023-08-04 Hitoshi Iida, Tatsuyoshi Kono, Chih-Chun Lee, Preethi Krishnan, Matthew C. Arvin, Staci A. Weaver, Timothy S. Jarvela, Renato C. S. Branco, Madeline R. McLaughlin, Robert N. Bone, Xin Tong, Peter Arvan, Iris Lindberg, Carmella Evans-Molina
-
Transcriptome-wide association study-derived genes as potential visceral adipose tissue-specific targets for type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2023-08-04 Haibo Tang, Jie Wang, Peizhi Deng, Yalan Li, Yaoquan Cao, Bo Yi, Liyong Zhu, Shaihong Zhu, Yao Lu
-
Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study Diabetol. (IF 8.2) Pub Date : 2023-08-03 Charlotte Skriver, Søren Friis, Lotte B. Knudsen, Andrei-Mircea Catarig, Alice J. Clark, Christian Dehlendorff, Lina S. Mørch
-
Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers Diabetol. (IF 8.2) Pub Date : 2023-08-02 Alexander C. Falkentoft, Thomas Alexander Gerds, Bochra Zareini, Filip K. Knop, Lars Køber, Christian Torp-Pedersen, Morten Schou, Niels E. Bruun, Anne-Christine Ruwald
-
SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study Diabetol. (IF 8.2) Pub Date : 2023-07-28 Matthew Anson, Sizheng S. Zhao, Philip Austin, Gema H. Ibarburu, Rayaz A. Malik, Uazman Alam
-
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study Diabetol. (IF 8.2) Pub Date : 2023-07-28 Vanja Kosjerina, Bendix Carstensen, Hanan Amadid, Dorte Vistisen
-
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease Diabetol. (IF 8.2) Pub Date : 2023-07-27 Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
-
Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial Diabetol. (IF 8.2) Pub Date : 2023-07-26 Yukari Kobayashi, Jin Long, Shozen Dan, Neil M. Johannsen, Ruth Talamoa, Sonia Raghuram, Sukyung Chung, Kyla Kent, Marina Basina, Cynthia Lamendola, Francois Haddad, Mary B. Leonard, Timothy S. Church, Latha Palaniappan
-
Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell Diabetol. (IF 8.2) Pub Date : 2023-07-25 Peter J. Thompson, Jasmine Pipella, Guy A. Rutter, Herbert Y. Gaisano, Pere Santamaria
-
Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production Diabetol. (IF 8.2) Pub Date : 2023-07-22 Yael Riahi, Aviram Kogot-Levin, Liat Kadosh, Bella Agranovich, Assaf Malka, Michael Assa, Ron Piran, Dana Avrahami, Benjamin Glaser, Eyal Gottlieb, Fields Jackson, Erol Cerasi, Ernesto Bernal-Mizrachi, Aharon Helman, Gil Leibowitz
-
Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial Diabetol. (IF 8.2) Pub Date : 2023-07-18 Anupam Garrib, Sokoine Kivuyo, Katie Bates, Kaushik Ramaiya, Duolao Wang, Edna Majaliwa, Rehema Simbauranga, Godbless Charles, Erik van Widenfelt, Huanyan Luo, Uazman Alam, Moffat J. Nyirenda, Shabbar Jaffar, Sayoki Mfinanga
-
Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells Diabetol. (IF 8.2) Pub Date : 2023-07-18 Ruchi Shah, Tanya M. Spektor, Daniel J. Weisenberger, Hui Ding, Rameshwar Patil, Cynthia Amador, Xue-Ying Song, Steven T. Chun, Jake Inzalaco, Sue Turjman, Sean Ghiam, Jiho Jeong-Kim, Sasha Tolstoff, Sabina V. Yampolsky, Onkar B. Sawant, Yaron S. Rabinowitz, Ezra Maguen, Pedram Hamrah, Clive N. Svendsen, Mehrnoosh Saghizadeh, Julia Y. Ljubimova, Andrei A. Kramerov, Alexander V. Ljubimov
-
Genetics of diabetes-associated microvascular complications Diabetol. (IF 8.2) Pub Date : 2023-07-14 Valeriya Lyssenko, Allan Vaag
-
An unwelcome inheritance: childhood obesity after diabetes in pregnancy Diabetol. (IF 8.2) Pub Date : 2023-07-13 Claire L. Meek
-
Utility of genetic risk scores in type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2023-07-13 Amber M. Luckett, Michael N. Weedon, Gareth Hawkes, R. David Leslie, Richard A. Oram, Struan F. A. Grant
-
Socioeconomic aspects of incretin-based therapy Diabetol. (IF 8.2) Pub Date : 2023-07-12 Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas
-
Incretin hormones and type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2023-07-11 Michael A. Nauck, Timo D. Müller
-
Genetic associations vary across the spectrum of fasting serum insulin: results from the European IDEFICS/I.Family children’s cohort Diabetol. (IF 8.2) Pub Date : 2023-07-07 Kirsten Mehlig, Ronja Foraita, Rajini Nagrani, Marvin N. Wright, Stefaan De Henauw, Dénes Molnár, Luis A. Moreno, Paola Russo, Michael Tornaritis, Toomas Veidebaum, Lauren Lissner, Jaakko Kaprio, Iris Pigeot
-
Not all very-low-carbohydrate diets are created equal. Reply to Conte C, Camajani E, Lai A, Caprio M [letter]. Diabetol. (IF 8.2) Pub Date : 2023-07-06 Andrew N Reynolds,Hana Kahleova,Matti Uusitupa,Kjeld Hermansen,Anne-Marie Aas,Ursula Schwab,Michael E J Lean,Andreas Pfeiffer,Jordi Salas-Salvadó,Jim I Mann
-
Not all very-low-carbohydrate diets are created equal. Diabetol. (IF 8.2) Pub Date : 2023-07-05 Caterina Conte,Elisabetta Camajani,Alessio Lai,Massimiliano Caprio
-
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review Diabetol. (IF 8.2) Pub Date : 2023-05-24 Caroline B. Terwee, Petra J. M. Elders, Marieke T. Blom, Joline W. Beulens, Olaf Rolandsson, Alize A. Rogge, Matthias Rose, Nicola Harman, Paula R. Williamson, Frans Pouwer, Lidwine B. Mokkink, Femke Rutters
-
Further investigation of the association between diabetes status and body composition and whether this association is moderated by sex. Reply to Mai Y [letter]. Diabetol. (IF 8.2) Pub Date : 2023-07-01 Rianneke de Ritter,Coen D A Stehouwer
-
Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study Diabetol. (IF 8.2) Pub Date : 2023-06-30 Min Fan, Anna-Janina Stephan, Karl Emmert-Fees, Annette Peters, Michael Laxy
-
100 years of glucagon and 100 more Diabetol. (IF 8.2) Pub Date : 2023-06-27 Nicolai J. Wewer Albrechtsen, Jens J. Holst, Alan D. Cherrington, Brian Finan, Lise Lotte Gluud, E. Danielle Dean, Jonathan E. Campbell, Stephen R. Bloom, Tricia M.-M. Tan, Filip K. Knop, Timo D. Müller
-
Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline Diabetol. (IF 8.2) Pub Date : 2023-06-23 Karis Little, Aditi Singh, Angel Del Marco, María Llorián-Salvador, Maria Vargas-Soria, Mireia Turch-Anguera, Montse Solé, Noëlle Bakker, Sarah Scullion, Joan X. Comella, Ingeborg Klaassen, Rafael Simó, Monica Garcia-Alloza, Vijay K. Tiwari, Alan W. Stitt
-
Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation Diabetol. (IF 8.2) Pub Date : 2023-06-17 Sandra Hummel, Johanna Carl, Nadine Friedl, Christiane Winkler, Kerstin Kick, Joanna Stock, Franziska Reinmüller, Claudia Ramminger, Jennifer Schmidt, Dominik Lwowsky, Sonja Braig, Desiree Dunstheimer, Uwe Ermer, Eva-Maria Gerstl, Leonie Weber, Nicole Nellen-Hellmuth, Susanne Brämswig, Marina Sindichakis, Stefanie Tretter, Anja Lorrmann, Ezio Bonifacio, Anette-G. Ziegler, Peter Achenbach
-
How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials Diabetol. (IF 8.2) Pub Date : 2023-06-20 Oliver Kuss, Marie Elisabeth Opitz, Lea Verena Brandstetter, Sabrina Schlesinger, Michael Roden, Annika Hoyer
-
Sarah A. Hills RGN MSc, 28 September 1960–1 May 2023 Diabetol. (IF 8.2) Pub Date : 2023-06-16 Andrew J. M. Boulton, Ele Ferrannini, Philippe A. Halban
-
Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts Diabetol. (IF 8.2) Pub Date : 2023-06-17 Daniela Zanetti, Laurel Stell, Stefan Gustafsson, Fahim Abbasi, Philip S. Tsao, Joshua W. Knowles, Björn Zethelius, Johan Ärnlöv, Beverley Balkau, Mark Walker, Laura C. Lazzeroni, Lars Lind, John R. Petrie, Themistocles L. Assimes
-
Further investigation of the association between diabetes status and body composition and whether this association is moderated by sex. Diabetol. (IF 8.2) Pub Date : 2023-06-15 Yanpei Mai
-
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy Diabetol. (IF 8.2) Pub Date : 2023-06-14 Sandra S. Hammer, Tim F. Dorweiler, Delaney McFarland, Yvonne Adu-Agyeiwaah, Natalia Mast, Nicole El-Darzi, Seth D. Fortmann, Sunil Nooti, Devendra K. Agrawal, Irina A. Pikuleva, George S. Abela, Maria B. Grant, Julia V. Busik